Course of Improvement in Depressive Symptoms to a Single Intravenous Infusion of Ketamine vs Add-on Riluzole: Results from a 4-Week, Double-Blind, Placebo-Controlled Study von IBRAHIM, Lobna, DIAZGRANADOS, Nancy, ZARATE, Carlos A, FRANCO-CHAVES, Jose, BRUTSCHE, Nancy, HENTER, Ioline D, KRONSTEIN, Phillip, MOADDEL, Ruin, WAINER, Irving, LUCKENBAUGH, David A, MANJI, Husseini K

Volltext

Tackling Challenging Data Integrity Topics in 2020: Update on Good Clinical Practice Perspectives from the US FDA and MHRA UK von Khin, Ni A., Grandinetti, Cheryl, Dixey, Hayley, Yu, Bei, Skeete, Rachel, Ayalew, Kassa, Budwal‐Jagait, Mandy, Cho, Seongeun‐Julia, Dasgupta, Arindam, Fisher, Andrew, Kleppinger, Cynthia, Kronstein, Phillip D., Martin, Jennifer, McGuinness, Michael, Mulinde, Jean, Vinter, Stephen, Wakelin‐Smith, Jason, Walker, Paula, Francis, Gail

Volltext

Data Integrity in Global Clinical Trials: Discussions From Joint US Food and Drug Administration and UK Medicines and Healthcare Products Regulatory Agency Good Clinical Practice W... von Khin, Ni A., Francis, Gail, Mulinde, Jean, Grandinetti, Cheryl, Skeete, Rachel, Yu, Bei, Ayalew, Kassa, Cho, Seongeun‐Julia, Fisher, Andrew, Kleppinger, Cynthia, Ayala, Ruben, Bonapace, Charles, Dasgupta, Arindam, Kronstein, Phillip D., Vinter, Stephen

Volltext

Publisher Correction: Descriptive Analysis of Good Clinical Practice Inspection Findings from U.S. Food and Drug Administration and European Medicines Agency von Sellers, Jenn W., Mihaescu, Camelia M., Ayalew, Kassa, Kronstein, Phillip D., Yu, Bei, Ning, Yang-Min, Rodriguez, Miguel, Williams, LaKisha, Khin, Ni A.

Volltext

Correction to: Descriptive Analysis of Good Clinical Practice Inspection Findings from U.S. Food and Drug Administration and European Medicines Agency von Sellers, Jenn W., Mihaescu, Camelia M., Ayalew, Kassa, Kronstein, Phillip D., Yu, Bei, Ning, Yang-Min, Rodriguez, Miguel, Williams, LaKisha, Khin, Ni A.

Volltext

Descriptive Analysis of Good Clinical Practice Inspection Findings from U.S. Food and Drug Administration and European Medicines Agency von Sellers, Jenn W., Mihaescu, Camelia M., Ayalew, Kassa, Kronstein, Phillip D., Yu, Bei, Ning, Yang-Min, Rodriguez, Miguel, Williams, LaKisha, Khin, Ni A.

Volltext

Comparison of Good Clinical Practice Inspection Processes for Marketing Applications Between the United States Food and Drug Administration and the European Medicines Agency von Ayalew, Kassa, Ning, Yang-Min, Foringer, Michelle J., Leibenhaut, Susan, Sellers, Jenn W., Yu, Bei, Kronstein, Phillip D., Higgerson, Agata, Mihaescu, Camelia, Rodriguez, Miguel, Williams, LaKisha, Khin, Ni A.

Volltext

A Randomized Add-on Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Bipolar Depression von Diazgranados, Nancy, Ibrahim, Lobna, Brutsche, Nancy E, Newberg, Andrew, Kronstein, Phillip, Khalife, Sami, Kammerer, William A, Quezado, Zenaide, Luckenbaugh, David A, Salvadore, Giacomo, Machado-Vieira, Rodrigo, Manji, Husseini K, Zarate, Carlos A

Volltext

The United States Food and Drug Administration’s Innovative Alternative Tools to Evaluate Good Clinical Practice During the COVID-19 Public Health Emergency von Ayalew, Kassa, Sellers, Jenn, Kronstein, Phillip D., Muldowney, Laurie, Gebbia, Emily, Mulinde, Jean, Burrow, David

Volltext

A Randomized Add-on Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Bipolar Depression von Diazgranados, Nancy, Ibrahim, Lobna, Brutsche, Nancy E, Newberg, Andrew, Kronstein, Phillip, Khalife, Sami, Kammerer, William A, Quezado, Zenaide, Luckenbaugh, David A, Salvadore, Giacomo, Machado-Vieira, Rodrigo, Manji, Husseini K, Zarate, Carlos A

Volltext